Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country.
Founded by former Illumina, Grail and Google leaders, Hepta is applying the technological, genomic and commercialization expertise that made liquid biopsy possible in oncology to the far larger field ...
Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback